annual cash & cash equivalents:
$95.39M+$67.49M(+241.93%)Summary
- As of today (July 27, 2025), BLFS annual cash & cash equivalents is $95.39 million, with the most recent change of +$67.49 million (+241.93%) on December 31, 2024.
- During the last 3 years, BLFS annual cash & cash equivalents has risen by +$25.53 million (+36.54%).
- BLFS annual cash & cash equivalents is now at all-time high.
Performance
BLFS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$66.94M-$28.44M(-29.82%)Summary
- As of today (July 27, 2025), BLFS quarterly cash & cash equivalents is $66.94 million, with the most recent change of -$28.44 million (-29.82%) on March 31, 2025.
- Over the past year, BLFS quarterly cash & cash equivalents has increased by +$37.25 million (+125.45%).
- BLFS quarterly cash & cash equivalents is now -29.82% below its all-time high of $95.39 million, reached on December 31, 2024.
Performance
BLFS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLFS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +241.9% | +125.5% |
| 3 y3 years | +36.5% | +12.6% |
| 5 y5 years | +1379.3% | +946.0% |
BLFS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +390.6% | -29.8% | +250.4% |
| 5 y | 5-year | at high | +1379.3% | -29.8% | +250.4% |
| alltime | all time | at high | >+9999.0% | -29.8% | >+9999.0% |
BLFS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $66.94M(-29.8%) |
| Dec 2024 | $95.39M(+241.9%) | $95.39M(+297.8%) |
| Sep 2024 | - | $23.98M(+8.9%) |
| Jun 2024 | - | $22.01M(-25.9%) |
| Mar 2024 | - | $29.69M(+6.4%) |
| Dec 2023 | $27.90M(+43.5%) | $27.90M(+45.0%) |
| Sep 2023 | - | $19.23M(-10.1%) |
| Jun 2023 | - | $21.40M(+12.0%) |
| Mar 2023 | - | $19.11M(-1.7%) |
| Dec 2022 | $19.44M(-72.2%) | $19.44M(-28.1%) |
| Sep 2022 | - | $27.04M(+12.6%) |
| Jun 2022 | - | $24.00M(-59.6%) |
| Mar 2022 | - | $59.46M(-14.9%) |
| Dec 2021 | $69.86M(-22.7%) | $69.86M(-7.0%) |
| Sep 2021 | - | $75.10M(-1.5%) |
| Jun 2021 | - | $76.25M(-14.3%) |
| Mar 2021 | - | $89.01M(-1.5%) |
| Dec 2020 | $90.40M(+1302.0%) | $90.40M(-3.8%) |
| Sep 2020 | - | $93.98M(+214.5%) |
| Jun 2020 | - | $29.88M(+366.9%) |
| Mar 2020 | - | $6.40M(-0.7%) |
| Dec 2019 | $6.45M(-79.0%) | $6.45M(-69.6%) |
| Sep 2019 | - | $21.20M(+8.1%) |
| Jun 2019 | - | $19.62M(-38.4%) |
| Mar 2019 | - | $31.82M(+3.8%) |
| Dec 2018 | $30.66M(+360.1%) | $30.66M(-5.3%) |
| Sep 2018 | - | $32.38M(+128.6%) |
| Jun 2018 | - | $14.17M(+101.4%) |
| Mar 2018 | - | $7.03M(+5.5%) |
| Dec 2017 | $6.66M(+374.0%) | $6.66M(+135.4%) |
| Sep 2017 | - | $2.83M(+22.3%) |
| Jun 2017 | - | $2.31M(+1.1%) |
| Mar 2017 | - | $2.29M(+62.9%) |
| Dec 2016 | $1.41M(-35.3%) | $1.41M(+2.7%) |
| Sep 2016 | - | $1.37M(+3.8%) |
| Jun 2016 | - | $1.32M(-20.7%) |
| Mar 2016 | - | $1.66M(-23.5%) |
| Dec 2015 | $2.17M(-14.4%) | $2.17M(-7.6%) |
| Sep 2015 | - | $2.35M(-39.6%) |
| Jun 2015 | - | $3.90M(+31.1%) |
| Mar 2015 | - | $2.97M(+17.1%) |
| Dec 2014 | $2.54M(+1524.3%) | $2.54M(-22.5%) |
| Sep 2014 | - | $3.28M(-44.5%) |
| Jun 2014 | - | $5.90M(-54.0%) |
| Mar 2014 | - | $12.84M(+8114.7%) |
| Dec 2013 | $156.30K(-20.5%) | $156.30K(+97.1%) |
| Sep 2013 | - | $79.30K(+4.1%) |
| Jun 2013 | - | $76.20K(+23.9%) |
| Mar 2013 | - | $61.50K(-68.7%) |
| Dec 2012 | $196.50K(+1062.7%) | $196.50K(+2520.0%) |
| Sep 2012 | - | $7500.00(-95.2%) |
| Jun 2012 | - | $155.40K(+120.4%) |
| Mar 2012 | - | $70.50K(+317.2%) |
| Dec 2011 | $16.90K(+428.1%) | $16.90K(-15.9%) |
| Sep 2011 | - | $20.10K(-44.3%) |
| Jun 2011 | - | $36.10K(+2.8%) |
| Mar 2011 | - | $35.10K(+996.9%) |
| Dec 2010 | $3200.00(-97.7%) | $3200.00(+966.7%) |
| Sep 2010 | - | $300.00(-99.6%) |
| Jun 2010 | - | $67.90K(+2852.2%) |
| Mar 2010 | - | $2300.00(-98.3%) |
| Dec 2009 | $139.20K(+41.0%) | $139.20K(+45.3%) |
| Sep 2009 | - | $95.80K(+10.9%) |
| Jun 2009 | - | $86.40K(-79.8%) |
| Mar 2009 | - | $428.20K(+333.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $98.70K(+74.7%) | $98.70K(+16.0%) |
| Sep 2008 | - | $85.10K(-3.0%) |
| Jun 2008 | - | $87.70K(-35.6%) |
| Mar 2008 | - | $136.20K(+141.1%) |
| Dec 2007 | $56.50K(-52.4%) | $56.50K(-92.5%) |
| Sep 2007 | - | $754.40K(+6.7%) |
| Jun 2007 | - | $707.10K(+144.9%) |
| Mar 2007 | - | $288.70K(+143.2%) |
| Dec 2006 | $118.70K(-35.9%) | $118.70K(-75.4%) |
| Sep 2006 | - | $483.00K(-23.3%) |
| Jun 2006 | - | $629.90K(+1938.5%) |
| Mar 2006 | - | $30.90K(-83.3%) |
| Dec 2005 | $185.10K(-65.2%) | $185.10K(-39.5%) |
| Sep 2005 | - | $305.80K(+61.5%) |
| Jun 2005 | - | $189.40K(-47.6%) |
| Mar 2005 | - | $361.40K(-32.0%) |
| Dec 2004 | $531.70K(-32.5%) | $531.70K(-7.0%) |
| Sep 2004 | - | $571.80K(-21.1%) |
| Jun 2004 | - | $724.30K(-17.9%) |
| Mar 2004 | - | $882.70K(+12.0%) |
| Dec 2003 | $787.90K(+1074.2%) | $787.90K(>+9900.0%) |
| Sep 2003 | - | $2700.00(-82.4%) |
| Jun 2003 | - | $15.30K(-85.4%) |
| Mar 2003 | - | $104.60K(+55.9%) |
| Dec 2002 | $67.10K(-76.5%) | $67.10K(-75.4%) |
| Sep 2002 | - | $273.10K(-86.2%) |
| Jun 2002 | - | $1.97M(+1526.1%) |
| Mar 2002 | - | $121.30K(-57.6%) |
| Dec 2001 | $286.10K(-86.7%) | $286.10K(-19.1%) |
| Sep 2001 | - | $353.50K(+182.3%) |
| Jun 2001 | - | $125.20K(-88.5%) |
| Mar 2001 | - | $1.09M(-49.5%) |
| Dec 2000 | $2.15M(>+9900.0%) | $2.15M(-33.0%) |
| Sep 2000 | - | $3.21M(-39.2%) |
| Jun 2000 | - | $5.29M(>+9900.0%) |
| Mar 2000 | - | $29.30K(-78.3%) |
| Dec 1999 | $8000.00(-94.1%) | - |
| Dec 1998 | $135.20K(+9.0%) | $135.20K(+9.0%) |
| Dec 1997 | $124.00K(-93.0%) | $124.00K(-38.0%) |
| Sep 1997 | - | $200.00K(-75.0%) |
| Jun 1997 | - | $800.00K(-46.7%) |
| Mar 1997 | - | $1.50M(-40.0%) |
| Dec 1996 | $1.77M(+41.4%) | - |
| Sep 1996 | - | $2.50M(+99.9%) |
| Jun 1996 | - | $1.25M(-3.8%) |
| Jun 1996 | $1.25M(+11.9%) | - |
| Mar 1996 | - | $1.30M(+85.7%) |
| Dec 1995 | - | $700.00K(-36.4%) |
| Sep 1995 | - | $1.10M(-1.6%) |
| Jun 1995 | $1.12M(-53.4%) | $1.12M(-25.5%) |
| Mar 1995 | - | $1.50M(-37.5%) |
| Sep 1994 | - | $2.40M(0.0%) |
| Jun 1994 | $2.40M(+20.0%) | $2.40M(+140.0%) |
| Mar 1994 | - | $1.00M(-37.5%) |
| Dec 1993 | - | $1.60M(-36.0%) |
| Sep 1993 | - | $2.50M(+25.0%) |
| Jun 1993 | $2.00M(-13.0%) | $2.00M(+11.1%) |
| Mar 1993 | - | $1.80M(-5.3%) |
| Dec 1992 | - | $1.90M(+46.2%) |
| Sep 1992 | - | $1.30M(-43.5%) |
| Jun 1992 | $2.30M(-55.8%) | $2.30M(+155.6%) |
| Dec 1991 | - | $900.00K(-82.7%) |
| Jun 1991 | $5.20M(+126.1%) | $5.20M(+92.6%) |
| Sep 1990 | - | $2.70M(+17.4%) |
| Jun 1990 | $2.30M(+475.0%) | $2.30M(+475.0%) |
| Jun 1989 | $400.00K | $400.00K |
FAQ
- What is BioLife Solutions, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioLife Solutions, Inc.?
- What is BioLife Solutions, Inc. annual cash & cash equivalents year-on-year change?
- What is BioLife Solutions, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BioLife Solutions, Inc.?
- What is BioLife Solutions, Inc. quarterly cash & cash equivalents year-on-year change?
What is BioLife Solutions, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of BLFS is $95.39M
What is the all time high annual cash & cash equivalents for BioLife Solutions, Inc.?
BioLife Solutions, Inc. all-time high annual cash & cash equivalents is $95.39M
What is BioLife Solutions, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, BLFS annual cash & cash equivalents has changed by +$67.49M (+241.93%)
What is BioLife Solutions, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BLFS is $66.94M
What is the all time high quarterly cash & cash equivalents for BioLife Solutions, Inc.?
BioLife Solutions, Inc. all-time high quarterly cash & cash equivalents is $95.39M
What is BioLife Solutions, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, BLFS quarterly cash & cash equivalents has changed by +$37.25M (+125.45%)